- Home
- TVRD vs ARAY Comparison
TVRD vs ARAY Comparison
Compare TVRD & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVRD
- ARAY
- Stock Information
- Founded
- TVRD 2017
- ARAY 1990
- Country
- TVRD United States
- ARAY United States
- Employees
- TVRD N/A
- ARAY N/A
- Industry
- TVRD Biotechnology: Pharmaceutical Preparations
- ARAY Medical/Dental Instruments
- Sector
- TVRD Health Care
- ARAY Health Care
- Exchange
- TVRD Nasdaq
- ARAY Nasdaq
- Market Cap
- TVRD 246.5M
- ARAY 229.3M
- IPO Year
- TVRD N/A
- ARAY 2007
- Fundamental
- Price
- TVRD $28.98
- ARAY $1.52
- Analyst Decision
- TVRD Strong Buy
- ARAY
- Analyst Count
- TVRD 2
- ARAY 0
- Target Price
- TVRD $52.00
- ARAY N/A
- AVG Volume (30 Days)
- TVRD 48.4K
- ARAY 696.9K
- Earning Date
- TVRD 05-13-2025
- ARAY 04-30-2025
- Dividend Yield
- TVRD N/A
- ARAY N/A
- EPS Growth
- TVRD N/A
- ARAY N/A
- EPS
- TVRD N/A
- ARAY 0.01
- Revenue
- TVRD N/A
- ARAY $465,251,000.00
- Revenue This Year
- TVRD N/A
- ARAY $3.87
- Revenue Next Year
- TVRD N/A
- ARAY $0.09
- P/E Ratio
- TVRD N/A
- ARAY $229.59
- Revenue Growth
- TVRD N/A
- ARAY 8.06
- 52 Week Low
- TVRD $8.13
- ARAY $1.28
- 52 Week High
- TVRD $34.31
- ARAY $2.95
- Technical
- Relative Strength Index (RSI)
- TVRD N/A
- ARAY 45.44
- Support Level
- TVRD N/A
- ARAY $1.53
- Resistance Level
- TVRD N/A
- ARAY $1.77
- Average True Range (ATR)
- TVRD 0.00
- ARAY 0.07
- MACD
- TVRD 0.00
- ARAY -0.00
- Stochastic Oscillator
- TVRD 0.00
- ARAY 3.85
About TVRD Tvardi Therapeutics Inc. Common Stock
Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.
About ARAY Accuray Incorporated
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.